CN104434983A - Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines - Google Patents

Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines Download PDF

Info

Publication number
CN104434983A
CN104434983A CN201410752544.3A CN201410752544A CN104434983A CN 104434983 A CN104434983 A CN 104434983A CN 201410752544 A CN201410752544 A CN 201410752544A CN 104434983 A CN104434983 A CN 104434983A
Authority
CN
China
Prior art keywords
extract
mukller
ethanol
pectinifera
tro sehel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410752544.3A
Other languages
Chinese (zh)
Inventor
陈刚
裴月湖
王海峰
何凤军
白皎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Pharmaceutical University
Original Assignee
Shenyang Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Pharmaceutical University filed Critical Shenyang Pharmaceutical University
Priority to CN201410752544.3A priority Critical patent/CN104434983A/en
Publication of CN104434983A publication Critical patent/CN104434983A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/616Echinodermata, e.g. starfish, sea cucumbers or sea urchins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention belongs to the technical field of medicines and relates to an application of an asterina pectinifera extract in preparation of anti-tumor medicines and health foods. The extract is a dried asterina pectinifera whole body and is obtained by 75% ethanol extraction and elution and purification by macroporous resin. The extract obtained by the invention has relatively strong antitumor activity in vitro and can be used for preparing anti-tumor medicines and health foods with antitumor activity, such as anti-colon cancer medicines and the like.

Description

The extracting method of Potiria pectinifera (Mukller et Tro Sehel) extract and preparing the application in antitumor drug
Technical field:
The present invention relates to medical art, be specifically related to the method for extraction and purification of Potiria pectinifera (Mukller et Tro Sehel) anti-tumor active ingredient and the application in antitumor drug preparation thereof.
Background technology:
Asterias amurensis Lutken is that coastal aquaculture brings huge economic loss, and the appetite of Asterias amurensis Lutken is surprising, and an Asterias amurensis Lutken can eat up tens scallops for 1 day, causes huge economic loss to shellfishery.In order to reduce the economic loss and harm that Asterias amurensis Lutken brings, administer in the urgent need to the disaster brought Asterias amurensis Lutken, especially to two Common Species, asterias rollestoni and the Potiria pectinifera (Mukller et Tro Sehel)s of in above-mentioned Asterias amurensis Lutken, Qingdao sea area being caused to serious harm.In recent years, the medical value of Asterias amurensis Lutken is progressively taken seriously, and records according to Chinese Sea medicine dictionary, and the Potiria pectinifera (Mukller et Tro Sehel) itself in the middle of these two kinds has very high medical value.The drying entirety of Potiria pectinifera (Mukller et Tro Sehel) can be used as medicine, and has effect of kidney invigorating and YANG supporting, wind-damp dispelling, pain relieving, cures mainly the symptoms such as sexual impotence, lumbago due to pathogenic wind-dampness, stomachache.
Not to the preparation method of Potiria pectinifera (Mukller et Tro Sehel) extract and the relevant report of its anti-tumor activity in prior art.
Summary of the invention:
The object of this invention is to provide a kind of extraction and process for purification of Potiria pectinifera (Mukller et Tro Sehel) extract, described Potiria pectinifera (Mukller et Tro Sehel) extract contains anti-tumor active ingredient, can be advantageously applied to and prepare antitumor drug.
Potiria pectinifera (Mukller et Tro Sehel) extract of the present invention obtains by following technical solution:
(1) Potiria pectinifera (Mukller et Tro Sehel) is dry all, extracts with 75% ethanol;
(2) extracting solution is separated through macroporous adsorbent resin after concentrated, first carries out eluting with pure water and 10% ethanol, then carries out eluting with 20%-60% ethanol, obtain eluent;
Wherein, the extraction time of step (1) is 2-3 time, and extraction time is 1-3 hour.
Wherein, the macroporous resin described in step (2) is selected from D101.
The separating obtained fraction of 40% to 60% ethanol macroporous adsorbent resin in step (2), shows to have the effect well suppressing human colon cancer cell HCT116 propagation through the test of body outer cell proliferation Inhibition test.
Potiria pectinifera (Mukller et Tro Sehel) extract of the present invention can form compositions to prepare antitumor drug and food and health product separately or with other pharmaceutically acceptable compositions.
Described antitumor drug dosage form is capsule, tablet, oral formulations, microcapsule formulation, injection, suppository, spray or ointment.
Accompanying drawing illustrates:
Fig. 1 is that Potiria pectinifera (Mukller et Tro Sehel) extract suppresses human colon carcinoma HCT116 cell-proliferation activity result.
HX-4: Potiria pectinifera (Mukller et Tro Sehel) 75% ethanol extraction macroporous adsorbent resin 40% ethanol elution fraction; HX-6: Potiria pectinifera (Mukller et Tro Sehel) 75% ethanol extraction macroporous adsorbent resin 60% ethanol elution fraction.
Detailed description of the invention: the present invention will be further described below in conjunction with example, but instantiation does not do any restriction to the present invention
Example 1: the preparation of Potiria pectinifera (Mukller et Tro Sehel) extract
(1) dry all 5 kilograms of Potiria pectinifera (Mukller et Tro Sehel) (Asterina pectinifera), carries out extraction 3 times with 3 times amount 75% ethanol, each 3 hours.Merge extractive liquid.
(2) extracting solution is after concentrated after drying, and gained extractum water dissolution, is separated through D101 type macroporous adsorbent resin, first carries out eluting with pure water and 10% ethanol, then carries out eluting with 20% to 60% ethanol, collects 40% to 60% ethanol elution.
Example 2: Potiria pectinifera (Mukller et Tro Sehel) extract suppresses human colon carcinoma HCT116 cell to increase active testing
(1) cell culture
Human colon cancer cell HCT116 is from Human Sciences Research Resource Bank (Japanese mankind NSFC, Tokyo, Japan) obtain, be incubated in the RPMI RPMI-1640 containing 10% hot deactivation calf serum, 37 DEG C, 5% CO 2, cultivate under saturated humidity condition.Choose exponential phase cell to test.
(2) body outer cell proliferation Inhibition test
MTT method (MTT) detects cell growth status, and PC3 cell is planted in 96 well culture plates respectively, and each porocyte number is 5 × 10 3, be incubated in the RPMI RPMI-1640 containing 10% hot deactivation calf serum, at 37 DEG C, 5% CO 224 h are cultivated under condition.After cultivating 24 h, rinse cell with PBS, then add new culture fluid and the testing sample of series concentration respectively.Experimental group establishes 6 drug level groups, and the final concentration often organizing medicine is respectively 5,10,20,50,100,200 μ g/ml, and matched group adds the dimethyl sulfoxide (DMSO) of same concentration, cultivates 24 h.Cultivation terminates the front 4 every holes of h and adds 20 μ L MTT solution (5mg/ml), centrifugally abandons supernatant, and add the abundant dissolving crystallized thing of 200 μ L DMSO, microplate reader surveys 570 nm place absorbances.Because absorbance is directly proportional to viable count in culture fluid, so cell survival percentage rate can be calculated by absorbance.As shown in Figure 1, show through gradient elution fraction tumor growth inhibiting activity result, Asterias amurensis Lutken 75% ethanol extraction is separated through macroporous adsorbent resin acquired results, and 40% to 60% eluting fraction has very strong vitro inhibition human colon carcinoma HCT116 cell-proliferation activity.

Claims (6)

1. a Potiria pectinifera (Mukller et Tro Sehel) extract, is characterized in that, preparation process is as follows:
(1) Potiria pectinifera (Mukller et Tro Sehel) is dry all, extracts with 75% ethanol;
(2) extracting solution is separated through macroporous adsorbent resin after concentrated, carries out eluting, obtain eluent with 20%, 40%, 60% ethanol;
(3) collect the separating obtained fraction of 40% to 60% ethanol macroporous adsorbent resin, after concentrate drying, obtain Potiria pectinifera (Mukller et Tro Sehel) targeted activity extract.
2. Potiria pectinifera (Mukller et Tro Sehel) extract according to claim 1, is characterized in that, in described step (1), organic solvent is 75% ethanol.
3. Potiria pectinifera (Mukller et Tro Sehel) extract according to claim 1, is characterized in that, in described step (2), gradient elution concentration is the ethanol of 40% to 60% percentage.
4. Potiria pectinifera (Mukller et Tro Sehel) extract according to claim 3, is characterized in that collection 40% to 60% ethanol elution.
5. Potiria pectinifera (Mukller et Tro Sehel) extract is preparing the application in antitumor drug according to claim 1.
6. according to claim 5, it is characterized in that described antitumor drug is drugs against colon cancer.
CN201410752544.3A 2014-12-10 2014-12-10 Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines Pending CN104434983A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410752544.3A CN104434983A (en) 2014-12-10 2014-12-10 Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410752544.3A CN104434983A (en) 2014-12-10 2014-12-10 Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines

Publications (1)

Publication Number Publication Date
CN104434983A true CN104434983A (en) 2015-03-25

Family

ID=52882245

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410752544.3A Pending CN104434983A (en) 2014-12-10 2014-12-10 Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines

Country Status (1)

Country Link
CN (1) CN104434983A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1545927A (en) * 2003-12-06 2004-11-17 许淑芬 Preparation method of raw material for producing health food and pharmaceutical
KR20060088911A (en) * 2005-02-02 2006-08-07 김옥자 A process for preparation of ethanol-extracts of asterina petinifera
CN1840539A (en) * 2005-03-29 2006-10-04 郭承华 Salangane saponin and preparation method and use thereof
KR20090025422A (en) * 2007-09-06 2009-03-11 조월순 Effect of antioxdant, wrinkles protection, antibacterial, anti-inflammatory and whitening from asterina pectinifera extract
KR20090045627A (en) * 2007-11-02 2009-05-08 부경대학교 산학협력단 Polysaccharides extracted from asterina pectinifera which have an detoxication effect on a living body, and the preparation method thereof
KR20110044485A (en) * 2009-10-23 2011-04-29 (주)엔엘피 Ffect of whitening and uv protection from water soluble extract of asterina pectinifera

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1545927A (en) * 2003-12-06 2004-11-17 许淑芬 Preparation method of raw material for producing health food and pharmaceutical
KR20060088911A (en) * 2005-02-02 2006-08-07 김옥자 A process for preparation of ethanol-extracts of asterina petinifera
CN1840539A (en) * 2005-03-29 2006-10-04 郭承华 Salangane saponin and preparation method and use thereof
KR20090025422A (en) * 2007-09-06 2009-03-11 조월순 Effect of antioxdant, wrinkles protection, antibacterial, anti-inflammatory and whitening from asterina pectinifera extract
KR20090045627A (en) * 2007-11-02 2009-05-08 부경대학교 산학협력단 Polysaccharides extracted from asterina pectinifera which have an detoxication effect on a living body, and the preparation method thereof
KR20110044485A (en) * 2009-10-23 2011-04-29 (주)엔엘피 Ffect of whitening and uv protection from water soluble extract of asterina pectinifera

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ZHANQIANG LI: "《Three new steroid glycosides from the starfish asterina pectinifera》", 《NATURAL PRODUCT RESEARCH》 *
左海娇: "《海燕内脏脑苷脂的分离纯化及抗肿瘤活性研究》", 《大连海洋大学硕士学位论文》 *
郭承华: "《海燕皂苷及其它活性物质的制备及其生物功能研究》", 《中国海洋大学 研究生学位论文》 *
郭承华等: "《黄海产海燕(Asterina pectinifera)海星皂苷的制备 》", 《海洋通报》 *

Similar Documents

Publication Publication Date Title
Hu et al. The research progresses and future prospects of Tetrastigma hemsleyanum Diels et Gilg: A valuable Chinese herbal medicine
CN101181317B (en) Purslane extract as well as preparation method and application thereof
CN104825500B (en) Ganoderma leucocontextum extract, extraction method and application thereof
Liu et al. An in vivo and in vitro assessment of the anti-inflammatory, antinociceptive, and immunomodulatory activities of Clematis terniflora DC. extract, participation of aurantiamide acetate
CN103272007A (en) Paeonia plant extract and preparation method and applications thereof
CN103316096A (en) General flavone extract of seeds of nigella damascena l., nigella sativa l. or nigella glandulifera freyn et sint., and preparation method and use thereof
Okonogi et al. Anti-inflammatory effects of compounds from Polygonum odoratum
CN101824014B (en) Compounds with anti-tumor activity in chloranthus japonicus and purpose thereof
CN104382968B (en) Extraction method of andrographolide, andrographolide pharmaceutical composition and application
CN104274502B (en) A kind of extracting method of the efficient antiinflammatory action compound of euscaphis konishii, product
Zhang et al. Effects of space flight on the chemical constituents and anti-inflammatory activity of licorice (Glycyrrhiza uralensis Fisch)
CN106083556B (en) Azulene structural compounds and its extraction separation method in purslane
CN102659746A (en) Ailanthus flower extract as well as preparation method and application of active ingredients brevifolin of ailanthus flower extract
CN102898322B (en) Compound and preparation method and application thereof
CN104434983A (en) Extraction method of asterina pectinifera extract and application of extract in preparing anti-tumor medicines
CN111150754B (en) Application of chestnut flower extract in preparation of food or anti-inflammatory drugs
CN107308269A (en) A kind of preparation method of the luxuriant boisiana extract of suede and its application of extract
CN102988525A (en) Preparation method for total lignans in hawthorn seeds, and novel application
CN103420971B (en) Antitumor compounds derived from G. nujiangnsis, and preparation method and application thereof
CN102000136B (en) Method for extracting components having antibacterial activity from fruit of pedunculate herpetospermum
CN103520195A (en) Application of clitocine in preparation of sensitizer
CN109718268A (en) The preparation method of Ormosia hosiei seed extract and its application in anti-inflammatory drug
CN104147565B (en) Extraction method for mioga ginger antineoplastic active component
CN108295052A (en) The application of I. henry Diels glycosides ether and composition in urarthritis
US20210290712A1 (en) Erodium crassifolium l'her plant extracts and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150325